Thrombotic risk in stable atherosclerotic disease
Organized with the support of Bayer
Vendredi 19 Janvier 2018 14:00-15:30 Bordeaux Amphitheatre
Sponsored main session (organized with the support of Industry)
14:00 • Jean-Philippe Collet
Rationale for an antithrombotic therapy
14:20 • Jean-Guillaume Dillinger
Aspirin, yes... but
14:40 • Denis Angoulvant
What's new since CAPRIE?
15:00 • Victor Aboyans
What about anticoagulation?